We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTI
3426
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$65K ﹤0.01%
+2,034
New +$49.9K
EPZM
3427
DELISTED
Epizyme, Inc
EPZM
$65K ﹤0.01%
5,424
-11,897
-69% -$159K
CM icon
3428
Canadian Imperial Bank of Commerce
CM
$112B
$64K ﹤0.01%
1,726
+712
+70% +$26.1K
GFL icon
3429
GFL Environmental
GFL
$15B
$64K ﹤0.01%
3,011
+2,969
+7,069% +$59.7K
GSK icon
3430
GSK
GSK
$98.2B
$64K ﹤0.01%
1,350
+1,161
+614% +$58.2K
HWC icon
3431
Hancock Whitney
HWC
$6.37B
$64K ﹤0.01%
3,425
-14,904
-81% -$292K
IMUX icon
3432
Immunic
IMUX
$220M
$64K ﹤0.01%
345
+231
+203% +$37.8K
KRP icon
3433
Kimbell Royalty Partners
KRP
$1.54B
$64K ﹤0.01%
+10,443
New +$84.3K
WRI
3434
DELISTED
Weingarten Realty Investors
WRI
$64K ﹤0.01%
3,787
-12,753
-77% -$225K
MFGP
3435
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$64K ﹤0.01%
19,798
+3,971
+25% +$15.9K
CBUS icon
3436
Cibus
CBUS
$124M
$63K ﹤0.01%
228
+186
+443% +$50.4K
CSBR icon
3437
Champions Oncology
CSBR
$68.8M
$63K ﹤0.01%
6,843
+1,554
+29% +$13.8K
GMAB icon
3438
Genmab
GMAB
$19.2B
$63K ﹤0.01%
+1,725
New +$62.4K
SCHB icon
3439
Schwab US Broad Market ETF
SCHB
$45.2B
$63K ﹤0.01%
4,740
-130,128
-96% -$1.71M
CORR
3440
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$63K ﹤0.01%
10,861
+7,973
+276% +$66K
MRLN
3441
DELISTED
Marlin Business Services Corp
MRLN
$63K ﹤0.01%
8,972
+7,099
+379% +$51.7K
AU icon
3442
AngloGold Ashanti
AU
$48.8B
$62K ﹤0.01%
2,360
+2,316
+5,264% +$69.3K
HHH icon
3443
Howard Hughes
HHH
$4B
$62K ﹤0.01%
1,123
+829
+282% +$44.3K
NRIX icon
3444
Nurix Therapeutics
NRIX
$2.77B
$62K ﹤0.01%
+1,788
New +$45.1K
PAVM icon
3445
PAVmed
PAVM
$33M
$62K ﹤0.01%
77
+22
+40% +$19.6K
TNK icon
3446
Teekay Tankers
TNK
$2.97B
$62K ﹤0.01%
5,662
-9,399
-62% -$123K
VFF icon
3447
Village Farms International
VFF
$306M
$62K ﹤0.01%
13,551
+13,467
+16,032% +$74K
DMS
3448
DELISTED
Digital Media Solutions, Inc.
DMS
$62K ﹤0.01%
+536
New +$69.3K
AUTL
3449
Autolus Therapeutics
AUTL
$559M
$61K ﹤0.01%
5,203
+4,313
+485% +$62.5K
ENTA icon
3450
Enanta Pharmaceuticals
ENTA
$386M
$61K ﹤0.01%
1,331
-1,686
-56% -$81.7K
136 137
138
139 140

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.